Economic Evaluation of Carfilzomib+Dexamethasone (Kd) Vs Bortezomib+Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma (R/RMM)
| Autor: | Jakubowiak, Andrzej, Majer, Istvan Matyas *, Houisse, Ivan *, Benedict, Agnes *, Campioni, Marco *, Panjabi, Sumeet *, Ailawadhi, Sikander |
|---|---|
| Zdroj: | In Blood 2 December 2016 128(22):3582-3582 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|